Travel support request for US participants in BIOT-ESBES meeting (Istanbul, Turkey) from September 23-26, 2012

为 2012 年 9 月 23 日至 26 日参加 BIOT-ESBES 会议（土耳其伊斯坦布尔）的美国与会者申请差旅补助

• 批准号: 1246225
• 负责人: William Kelly
• 金额: $ 2万
• 依托单位: Villanova University
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-15 至 2013-08-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1246225&HistoricalAwards=false
• 关键词: Travel; support; request; US; participants

1246225/ KellyThis award from the Biotechnology, Biochemical and Biomass Engineering Program of the National Science Foundation will support the participation of thirteen US scientists and engineers who are participating in the 9th European Symposium(http://events.dechema.de/best2012) on Biochemical Engineering to be held in Istanbul, Turkey from September 23-26, 2012. Bioengineering and the separation of biomolecules are the main focus of this jointly organized event of BIOT, ESBES and ISPPP. The symposium will take place at the same time and at the same place as ECB15, the 15th European Congress on Biotechnology, allowing for the unique opportunity to visit the complete scientific program of all these congresses. The idea of this summit is to bring together the international scientific communities in these fields, to foster communication, cooperation, and cross-disciplinary exchange of ideas in analyzing the impact of the life sciences industry in addressing humanity's great challenges. This event will provide a unique platform for scientists both from industry and academia to discover new science, technologies, processes and applications.The meeting is being organized by a coordination group consisting of eight individuals from ESBES and William J. Kelly (Villanova University, PA/USA) who, as a current member of the ACS BIOT executive board, is representing ACS BIOT. A diverse ACS BIOT subcommittee was created for the purposes of identifying US scientists and engineers to invite as technical presenters and keynote speakers at the ECB15 conference in Istanbul.Intellectual MeritThis conference is a pre-eminent venue in Europe for discussing research at the cutting edge of this diverse and rapidly expanding field. This particular meeting provides a unique opportunity for US scientists from not one but these four different but overlapping technical areas involved, to interact with their European counterparts. The thirteen US participants will be primarily chairing or giving technical presentations in the following areas: Frontiers and innovations in biopharmaceuticals, Nanotechnology in bioprocessing, Stem cell bioengineering and cell therapy and tissue engineering and Systems biotechnology and metabolic engineering. Five of the US speakers were invited to give keynote talks to launch sessions that would be followed by shorter technical talks in the same topical area.Broader ImpactsThe focus of this conference will be on research at the cutting-edge of the field of biotechnology in Europe and the US. The conference organizers have made a significant effort to invite and recruit US speakers and session chairs from groups underrepresented in science and engineering. Dr. Claudia Schmidt-Dannert from the University of Minnesota is one of the five US participants giving a keynote presentation. Furthermore, three of the thirteen US participants are from the US biopharmaceuticals industry and the remaining seven are US academics representing universities spanning the US from west to the east coasts. As a result of this first collaboration between BIOT and ESBES, there is the opportunity for increasing exchange between researchers in the flagship scientific organizations in Europe and the US in the areas of biotechnology. This is a first step in increased interaction between these two important research communities.

1246225/National Science Foundation的生物技术，生物化学和生物量工程计划获得的Kellythis奖将支持参加参加第9届欧洲研讨会的13名美国科学家和工程师（http://events.dechema.dechema.dechema.dechema.de/best2012）生化工程将于2012年9月23日至26日在土耳其伊斯坦布尔举行。生物工程和生物分子的分离是Biot，ESBES和ISPPP共同组织的事件的主要重点。该研讨会将与第15届欧洲生物技术大会ECB15同时举行，并在同一地点举行，这为参观所有这些国会的完整科学计划提供了独特的机会。这次峰会的想法是将这些领域的国际科学社区汇集在一起​​，以促进思想的交流，合作和跨学科交流，以分析生命科学行业在应对人类巨大挑战方面的影响。这项活动将为来自行业和学术界的科学家提供一个独特的平台，以发现新科学，技术，流程和应用。会议是由由Esbes和William J. Kelly（Villanova University，PA，Villanova University，Villanova University）组成的协调小组组织的。 /美国），作为ACS Biot执行委员会的现任成员，代表ACS Biot。创建了一个多样化的ACS Biot小组委员会，目的是确定美国科学家和工程师在伊斯坦布尔举行的ECB15会议上邀请技术主持人和主题演讲者。这个多样化，迅速扩展的领域。这次特殊会议为美国科学家提供了一个独特的机会，而不是其中一个，而是与欧洲同行互动的四个不同但重叠的技术领域。 13名美国参与者将主要主持或在以下领域主持或进行技术演讲：生物制药的前沿和创新，生物处理，干细胞生物工程和细胞疗法以及组织工程以及系统生物技术和系统生物技术和代谢工程的纳米技术。邀请了五位美国发言人进行主题演讲，以启动会议，随后在同一主题领域进行技术对话，Boader影响着这次会议的重点将在欧洲生物技术领域的最先进的研究上和美国。 会议组织者已经做出了巨大的努力，邀请并招募了科学和工程中代表性不足的团体的演讲者和会议主持人。明尼苏达大学的Claudia Schmidt-Dannert博士是美国五名参与者进行主题演讲的人之一。此外，美国13名参与者中有三名来自美国的生物制药行业，其余的七个是美国的学者，代表从西部到东海岸的美国。由于Biot和Esbes之间的首次合作，有机会在欧洲和美国在生物技术领域的旗舰科学组织中的研究人员之间进行交流。 这是增加这两个重要研究社区之间相互作用的第一步。